Tweet
In a breakthrough that challenges long-held medical assumptions, a pioneering clinical trial has successfully reversed corneal damage once deemed irreversible. The study, led by researchers at [Institution Name], utilized stem cell therapy to regenerate healthy corneal tissue in patients suffering from limbal stem cell deficiency (LSCD), a condition that causes blindness due to scarring and inflammation.
tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4 tR4